313 related articles for article (PubMed ID: 17038001)
1. Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings.
Kobayashi R; Yabe H; Hara J; Morimoto A; Tsuchida M; Mugishima H; Ohara A; Tsukimoto I; Kato K; Kigasawa H; Tabuchi K; Nakahata T; Ohga S; Kojima S;
Br J Haematol; 2006 Dec; 135(5):693-6. PubMed ID: 17038001
[TBL] [Abstract][Full Text] [Related]
2. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
[TBL] [Abstract][Full Text] [Related]
3. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
Osugi Y; Yagasaki H; Sako M; Kosaka Y; Taga T; Ito T; Yamamoto M; Ohara A; Sato T; Mimaya J; Tsukimoto I; Kojima S;
Haematologica; 2007 Dec; 92(12):1687-90. PubMed ID: 18055993
[TBL] [Abstract][Full Text] [Related]
4. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group.
McCann SR; Bacigalupo A; Gluckman E; Hinterberger W; Hows J; Ljungman P; Marin P; Nissen C; van't Veer Kerthof E; Raghavachar A
Bone Marrow Transplant; 1994 Mar; 13(3):233-7. PubMed ID: 8199566
[TBL] [Abstract][Full Text] [Related]
5. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
6. [Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results].
Novichkova GA; Maschan MA; Shipitsyna IP; Skvortsova IuV; Persiantseva MI; Lebedeva LL; Bobrynina VO; Baĭdil'dina DD; Goronkova OV; Solopova GG; Khachatrian LA; Petrova UN; Suntsova EV; Kalinina II; Sinitsyna VV; Skorobogatova EV; Balashov DN; Dyshlevaia ZM; Shelikhova LN; Kurnikova EE; Trakhtman PE; Maschan AA
Ter Arkh; 2010; 82(7):41-7. PubMed ID: 20853608
[TBL] [Abstract][Full Text] [Related]
7. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
[TBL] [Abstract][Full Text] [Related]
8. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.
Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G
Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856
[TBL] [Abstract][Full Text] [Related]
9. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
[TBL] [Abstract][Full Text] [Related]
11. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation for severe aplastic anemia in Japan.
Kanamaru A; Nagai K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
Storb R; Blume KG; O'Donnell MR; Chauncey T; Forman SJ; Deeg HJ; Hu WW; Appelbaum FR; Doney K; Flowers ME; Sanders J; Leisenring W
Biol Blood Marrow Transplant; 2001; 7(1):39-44. PubMed ID: 11215697
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia.
Werner EJ; Stout RD; Valdez LP; Harris RE
Pediatrics; 1989 Jan; 83(1):61-5. PubMed ID: 2642621
[TBL] [Abstract][Full Text] [Related]
15. Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
Bone Marrow Transplant; 1996 Dec; 18(6):1179-81. PubMed ID: 8971392
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem.
Aki SZ; Sucak GT; Ozkurt ZN; Yeğin ZA; Yağci M; Haznedar R
Transfus Apher Sci; 2009 Feb; 40(1):5-11. PubMed ID: 19121979
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
[TBL] [Abstract][Full Text] [Related]
18. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
19. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
20. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]